Jazz Pharmaceuticals (JAZZ)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

123.04

0.03%

After-hours Dec 13, 2024, 05:19 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05
Net Income	414.83M	-224.06M	-329.67M	238.62M	523.37M	447.10M	487.85M	396.83M	329.53M	57.33M	216.31M	288.59M	124.98M	32.78M	-6.84M	-184.34M	-138.83M	-59.39M	-85.16M
Depreciation & Amortization	638.70M	629.47M	552.48M	278.25M	370.16M	216.73M	165.15M	113.78M	108.06M	133.68M	82.09M	74.23M	7.83M	8.71M	9.10M	15.03M	10.53M	10.31M	5.44M
Stock-Based Compensation	226.84M	222.00M	189.01M	121.00M	110.56M	102.44M	106.90M	98.77M	91.55M	69.64M	44.55M	23.01M	20.70M	8.22M	5.96M	8.11M	6.06M	-	-
Other Working Capital	-214.04M	160.91M	36.62M	2.68M	-29.74M	64.89M	22.94M	19.55M	14.74M	49.20M	-28.68M	5.16M	5.32M	4.71M	-15.74M	3.11M	29.88M	15.92M	3.07M
Other Non-Cash Items	276.29M	926.92M	345.44M	484.15M	159.01M	98.16M	132.01M	45.04M	70.12M	239.98M	31.72M	-17.05M	125.38M	2.41M	14.00K	2.06M	25.56M	-23.67M	24.71M
Deferred Income Tax	-260.22M	-292.25M	69.20M	-136.94M	-236.61M	-88.81M	-225.59M	-41.16M	-61.21M	-43.42M	-10.10M	-113.86M	-123.70M	12.57M	-	26.81M	-11.91M	-	-
Change in Working Capital	-204.44M	9.90M	-47.95M	-85.44M	-150.08M	23.29M	26.77M	-22.72M	-6.11M	-51.44M	-80.96M	-5.16M	-3.59M	-5.81M	-24.11M	2.10M	27.50M	15.40M	2.85M
Operating Cash Flow	1.09B	1.27B	778.51M	899.65M	776.40M	798.90M	693.09M	590.54M	531.94M	405.76M	283.62M	249.75M	151.60M	58.87M	-15.88M	-130.23M	-81.09M	-57.35M	-52.16M
Capital Expenditures	-23.96M	-498.19M	-45.53M	-379.25M	-182.34M	-131.47M	-113.95M	-181.58M	-35.96M	-238.97M	-11.28M	-22.48M	-5.78M	-4.73M	-6.05M	-28.74M	-3.15M	-1.68M	-1.41M
Acquisitions	-	53.00M	-6.23B	-364.25M	-142.20M	111.10M	85.00M	-1.50B	33.70M	-828.68M	-	-448.61M	-4.50M	-	-	-	10.15M	150.00K	-146.12M
Purchase of Investments	-390.10M	-61.04M	-26.82M	-2.40B	-917.10M	-1.17B	-385.00M	-65.28M	-	-	-	-37.44M	-79.89M	-	-	-	-10.85M	-1.71M	-
Sales Maturities Of Investments	270.00M	60.00M	1.09B	1.75B	985.00M	855.00M	230.00M	173.75M	-	-	-	113.23M	4.03M	2.59M	1.00M	3.44M	10.85M	1.71M	5.95M
Other Investing Acitivies	-19.00M	-444.15M	1.05B	378.51M	101.33M	-63.20M	-85.00M	-173.75M	33.70M	-202.63M	-6.29M	-389.32M	4.90M	-1.41M	-1.07M	13.36M	-1.66M	25.00K	-12.18M
Investing Cash Flow	-163.06M	-446.23M	-5.21B	-1.01B	-155.30M	-394.49M	-268.95M	-1.75B	-2.25M	-1.07B	-11.28M	-395.29M	-81.23M	-2.14M	-6.12M	-11.94M	5.34M	-1.51M	-153.75M
Debt Repayment	-31.00M	-582.01M	3.87B	591.81M	-33.39M	-25.72M	-326.70M	816.34M	-167.12M	884.86M	87.52M	439.04M	-49.50M	-89.93M	-	38.45M	1.27M	2.19M	-
Common Stock Repurchased	-269.76M	-54.00K	-35.60M	-146.54M	-301.45M	-523.67M	-98.80M	-278.30M	-61.55M	-42.22M	-136.48M	-25.30M	-	-	-	-	-	-	-
Dividend Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Financial Acitivies	-4.49M	52.58M	99.66M	82.80M	41.09M	70.26M	16.39M	2.94M	14.35M	-129.77M	24.94M	9.49M	-	5.59M	5.91M	1.17M	-	15.00M	15.00M
Financial Cash Flow	-305.25M	-529.49M	3.97B	528.07M	-293.75M	-479.13M	-409.11M	540.99M	-214.32M	712.88M	-24.03M	448.53M	-33.08M	-27.53M	12.69M	64.13M	99.75M	117.19M	192.85M
Net Cash Flow	624.83M	290.03M	-466.32M	420.43M	327.72M	-76.41M	20.07M	-622.82M	304.74M	47.54M	249.31M	305.12M	37.28M	29.20M	-9.31M	-78.04M	24.00M	58.33M	-13.06M
Free Cash Flow	1.07B	773.78M	732.98M	520.39M	594.07M	667.43M	579.14M	408.95M	495.99M	166.79M	272.34M	227.28M	145.82M	54.14M	-21.93M	-158.97M	-84.24M	-59.03M	-53.58M